Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesDividends payablesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

cbdMD (YCBD) Cash & Equivalents (2016 - 2025)

Historic Cash & Equivalents for cbdMD (YCBD) over the last 10 years, with Q3 2025 value amounting to $2.3 million.

  • cbdMD's Cash & Equivalents fell 780.05% to $2.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.3 million, marking a year-over-year decrease of 780.05%. This contributed to the annual value of $2.3 million for FY2025, which is 780.05% down from last year.
  • cbdMD's Cash & Equivalents amounted to $2.3 million in Q3 2025, which was down 780.05% from $1.1 million recorded in Q2 2025.
  • cbdMD's 5-year Cash & Equivalents high stood at $26.4 million for Q3 2021, and its period low was $1.1 million during Q2 2025.
  • Over the past 5 years, cbdMD's median Cash & Equivalents value was $2.5 million (recorded in 2024), while the average stood at $7.6 million.
  • Per our database at Business Quant, cbdMD's Cash & Equivalents surged by 7815.89% in 2021 and then tumbled by 8711.43% in 2023.
  • cbdMD's Cash & Equivalents (Quarter) stood at $19.7 million in 2021, then crashed by 82.98% to $3.4 million in 2022, then tumbled by 55.11% to $1.5 million in 2023, then soared by 30.92% to $2.0 million in 2024, then rose by 14.77% to $2.3 million in 2025.
  • Its Cash & Equivalents was $2.3 million in Q3 2025, compared to $1.1 million in Q2 2025 and $1.8 million in Q1 2025.